JP2016069309A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016069309A5 JP2016069309A5 JP2014198864A JP2014198864A JP2016069309A5 JP 2016069309 A5 JP2016069309 A5 JP 2016069309A5 JP 2014198864 A JP2014198864 A JP 2014198864A JP 2014198864 A JP2014198864 A JP 2014198864A JP 2016069309 A5 JP2016069309 A5 JP 2016069309A5
- Authority
- JP
- Japan
- Prior art keywords
- bacterium
- bifidobacterium
- bilophila
- active ingredient
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186000 Bifidobacterium Species 0.000 claims description 9
- 241001495171 Bilophila Species 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims 2
- 229940009291 bifidobacterium longum Drugs 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 claims 1
- 206010053759 Growth retardation Diseases 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014198864A JP6247185B2 (ja) | 2014-09-29 | 2014-09-29 | バイロフィラ属細菌増殖抑制剤及びバイロフィラ属細菌増殖抑制方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014198864A JP6247185B2 (ja) | 2014-09-29 | 2014-09-29 | バイロフィラ属細菌増殖抑制剤及びバイロフィラ属細菌増殖抑制方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016069309A JP2016069309A (ja) | 2016-05-09 |
| JP2016069309A5 true JP2016069309A5 (cg-RX-API-DMAC7.html) | 2017-01-12 |
| JP6247185B2 JP6247185B2 (ja) | 2017-12-13 |
Family
ID=55865965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014198864A Active JP6247185B2 (ja) | 2014-09-29 | 2014-09-29 | バイロフィラ属細菌増殖抑制剤及びバイロフィラ属細菌増殖抑制方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6247185B2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250205261A1 (en) | 2022-03-18 | 2025-06-26 | Meiji Co., Ltd. | Composition for controlling growth of bacteria in the intestinal tract and use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010180146A (ja) * | 2009-02-04 | 2010-08-19 | Univ Of Tokyo | 腸管出血性大腸菌による感染死を抑制するための組成物及び方法 |
| JP4898859B2 (ja) * | 2009-03-05 | 2012-03-21 | 森永乳業株式会社 | 非発酵型酸性乳酸菌飲料とその製造方法 |
| EP2672980B1 (en) * | 2011-02-09 | 2017-12-06 | Lavivo AB | Synbiotic compositions for restoration and reconstitution of gut microbiota |
| JP2012180288A (ja) * | 2011-02-28 | 2012-09-20 | Morinaga Milk Ind Co Ltd | 抗菌剤 |
-
2014
- 2014-09-29 JP JP2014198864A patent/JP6247185B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014018596A3 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
| AR110684A1 (es) | Composiciones que comprenden cepas bacterianas y método de tratamiento | |
| EP4293033A3 (en) | Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides | |
| WO2016086210A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | |
| MY172363A (en) | Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof | |
| EP3409666A3 (en) | Seca inhibitors and methods of making and using thereof | |
| WO2013155468A3 (en) | Microbial strains and their use in animals | |
| PH12019502340A1 (en) | Probiotic molecules for reducing pathogen virulence | |
| RU2014151746A (ru) | Штаммы lactobacillus | |
| MX355955B (es) | Efecto antimicrobiano sinergico. | |
| MX2014011827A (es) | Inhibidores de 1,3,4 - oxadiazol y 1,3,4 - tiadiazol b-lactamasa. | |
| MX354047B (es) | Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. | |
| WO2016109852A3 (en) | Bacterial compositions | |
| MY191734A (en) | Antiseptic-tolerant lactic acid bacteria | |
| WO2015092548A3 (en) | Paenibacillus strains and compositions thereof that inhibit microorganisms | |
| MX382895B (es) | Suplemento dietético. | |
| EP3255140A4 (en) | Lactic acid bacteria, natural immunoactivator and infection preventative/therapeutic derived from said lactic acid bacteria, and food/beverage | |
| AU2018225957A1 (en) | Composition for alleviating mental health disorder | |
| JP2009232702A5 (cg-RX-API-DMAC7.html) | ||
| WO2012116254A3 (en) | Chrysophaentin analogs that inhibit ftsz protein | |
| WO2012073214A3 (en) | Heptose derivatives for use in the treatment of bacterial infections | |
| JP2018083761A5 (cg-RX-API-DMAC7.html) | ||
| JP2016069309A5 (cg-RX-API-DMAC7.html) | ||
| EP3195870A4 (en) | Agent for promoting growth of nonpathogenic oral indigenous bacteria or agent for improving oral bacterial flora, and composition for oral use | |
| WO2015108999A8 (en) | Bioactive heme-haloperoxidase compositions and methods of their use |